SHP 647

Drug Profile

SHP 647

Alternative Names: PF-00547659; PF-547659; SHP647

Latest Information Update: 02 Jun 2017

Price : $50

At a glance

  • Originator Pfizer
  • Class Antiulcers; Monoclonal antibodies
  • Mechanism of Action MADCAM1 protein inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity Yes

Highest Development Phases

  • Phase II Crohn's disease; Ulcerative colitis

Most Recent Events

  • 18 May 2017 Efficacy and adverse event data from the phase III TURANDOT trial in Ulcerative colitis released by Shire
  • 18 May 2017 Shire plans a pivotal phase III trial in the third quarter of 2017
  • 15 Dec 2016 Biomarkers information updated
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top